AI Assistant
Blog
Pricing
Log In
Sign Up
Comment on “Non-Proportional Hazards – an Evaluation of the MaxCombo Test in Cancer Clinical Trials” by the Cross-Pharma Non-Proportional Hazards Working Group
Details
Cite
Export
Add to List
This content is not available in your region!
Continue researching
here.
